Longshenrongfa Pharmaceutical Industry released its performance for the first three quarters, with a net profit attributable to the parent company of 27.0294 million yuan, an increase of 8.11%Zhitong·Oct 24, 2025 at 09:34 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry: Net profit loss of 926,700 yuan in the third quarterZhitong·Oct 24, 2025 at 08:28 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry: Zhao Zhengcai resigns as Chief Financial Officer, Xiao Rong takes overZhitong·Sep 26, 2025 at 08:45 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry: The holding subsidiary has obtained the renewed "Drug Manufacturing License"Zhitong·Sep 25, 2025 at 08:36 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry: Tongmai Oral Liquid Approved for Market SaleZhitong·Sep 19, 2025 at 08:26 AM300534-4.79%
Gansu Longshenrongfa Pharmaceutical Industry announced the implementation of the 2025 semi-annual dividend distributionZhitong·Sep 15, 2025 at 08:21 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry: In the first half of the year, the net profit attributable to the parent company was 27.9561 million yuan, a year-on-year increase of 27.48%Zhitong·Aug 22, 2025 at 08:55 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry: Currently no relevant business and expansion plans in the brain-computer interface fieldZhitong·Aug 18, 2025 at 01:13 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry: Obtained the drug production license after renewalZhitong·Aug 12, 2025 at 08:59 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry: The holding subsidiary has obtained the renewed "Drug Production License" and passed the drug GMP compliance inspectionZhitong·Aug 7, 2025 at 10:00 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry: Received the approval notice for the supplementary application of the clinical trial of Buprenorphine oral dissolving filmZhitong·Jul 30, 2025 at 08:47 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry: The holding subsidiary Guofang Testing has obtained the CNAS laboratory accreditation certificateZhitong·Jun 8, 2025 at 08:23 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry: A cash dividend of 0.2 yuan will be distributed for every 10 sharesZhitong·May 20, 2025 at 11:20 AM300534-4.79%
Longshenrongfa Pharmaceutical Industry released its first-quarter performance, with a net profit attributable to the parent company of 24.21 million yuan, an increase of 9.18%Zhitong·Apr 24, 2025 at 10:13 AM300534-4.79%
Midday Break | The three major indices of A-shares all rose36Kr·Apr 1, 2025 at 03:32 AM688390-3.42%300763-2.48%